Top compounds associated with response to MARCKSL1


Feature Type Standardized
Nominal ANOVA
mRNA Topotecan CTRPv2 pan-cancer AAC 0.21 1e-10
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.25 2e-10
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 2e-10
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 4e-10
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.2 6e-10
mRNA PL-DI CTRPv2 pan-cancer AAC 0.2 6e-10
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 7e-10
mRNA SN-38 CTRPv2 pan-cancer AAC 0.22 1e-09
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 1e-09
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.18 1e-09
Download CSV